The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
The role of hypoxia‐inducible factor 1 in tumor immune evasion
Abstract
Hypoxia‐inducible factor 1 (HIF‐1) plays an indispensable role in the hypoxic tumor microenvironment. Hypoxia and HIF‐1 are involved in multiple aspects of tumor progression, such as metastasis, angiogenesis, and immune evasion. In innate and adaptive immune systems, malignant tumor cells avoid their recognition and destruction by HIF‐1. Tumor immune evasion allows cancer cells to proliferate and metastasize and is associated with immunotherapy failure and chemoresistance. In the hypoxic tumor microenvironment, HIF‐1 signaling suppresses the innate and adaptive immune systems to evade immune attack by inducing the expression of immunosuppressive factors and immune checkpoint molecules, including vascular endothelial growth factor, prostaglandin E 2, and programmed death‐ligand 1/programmed death‐1. Moreover, HIF‐1 blocks tumor‐associated antigen presentation via major histocompatibility complex class I chain‐related/natural killer group 2, member D signaling. Tumor‐associated autophagy and the release of tumor‐derived exosomes contribute to HIF‐1‐mediated immune evasion. This review focuses on recent findings on the potential mechanism(s) underlying the effect of hypoxia and HIF‐1 signaling on tumor immune evasion in the hypoxic tumor microenvironment. The effects of HIF‐1 on immune checkpoint molecules, immunosuppressive molecules, autophagy, and exosomes have been described. Additionally, the potential role of HIF‐1 in the regulation of tumor‐derived exosomes, as well as the roles of HIF‐1 and exosomes in tumor evasion, are discussed. This study will contribute to our understanding of HIF‐1‐mediated tumor immune evasion, leading to the development of effective HIF‐1‐targeting drugs and immunotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601
RetractedMaroni, P., Bendinelli, P., Matteucci, E., Locatelli, A., Nakamura, T., Scita, G., & Desiderio, M. A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.465 · Cited by 26
RetractedExosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Chen, G., Huang, A. C., Zhang, W., Zhang, G., Wu, M., Xu, W., Yu, Z., Yang, J., Wang, B., Sun, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0392-8 · Cited by 2,813
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871 · cited 2×
“overexpression activates the vascular endothelial growth factor (VEGF) transcription, thereby stimulating the development of new blood vessels and contributing to tumor progression and metastasis.(50) Furthermore, HIF‐1 promotes tumor metastasis into other tissues by activating the transcription of target genes, such…”
BackgroundSpranger, S., Spaapen, R. M., Zha, Y., Williams, J., Meng, Y., Ha, T. T., & Gajewski, T. F. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006504 · Cited by 1,677 · cited 2×
“In melanoma metastases comprising CD8 T cells, the immunosuppressive factors IDO and PD‐L1 were observed to have higher expression levels, preventing T cell function.(92) The authors, in this context, focused their attention on two immunosuppressive molecules related to the CD8 T cell infiltration (PD‐L1 and IDO).”
BackgroundImmune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
The role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouysségur, J., & Mazure, N. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-09 · Cited by 1,501
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Jiang, X., Wang, J., Deng, X., Xiong, F., Ge, J., Xiang, B., Wu, X., Ma, J., Zhou, M., Li, X., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0928-4 · Cited by 1,457
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Poggio, M., Hu, T., Pai, C.-C., Chu, B., Belair, C. D., Chang, A., Montabana, E., Lang, U. E., Fu, Q., Fong, L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.016 · Cited by 1,376
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340 · cited 3×
“HIF‐1 is composed of an oxygen‐regulated α subunit (HIF‐1α) and an aryl hydrocarbon nuclear translocator β subunit (HIF‐1β).(29,47) HIF‐1α and HIF‐1β are basic helix–loop–helix/PER‐ARNT‐SIM (bHLH–PAS) homology domain proteins.”
BackgroundHIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Yamamoto, K., Venida, A., Yano, J., Biancur, D. E., Kakiuchi, M., Gupta, S., Sohn, A. S. W., Mukhopadhyay, S., Lin, E. Y., Parker, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2229-5 · Cited by 1,240
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Voron, T., Colussi, O., Marcheteau, E., Pernot, S., Nizard, M., Pointet, A.-L., Latreche, S., Bergaya, S., Benhamouda, N., Tanchot, C., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140559 · Cited by 1,179
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
Semenza, G. L. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104720 · Cited by 1,159
Hypoxic enhancement of exosome release by breast cancer cells
King, H. W., Michael, M. Z., & Gleadle, J. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-421 · Cited by 1,045
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011624 · Cited by 774
Wang, X., Luo, G., Zhang, K., Cao, J., Huang, C., Jiang, T., Liu, B., Su, L., & Qiu, Z. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3841 · Cited by 767
Self-citationHIF‐1 at the crossroads of hypoxia, inflammation, and cancer
Balamurugan, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.29519 · Cited by 572
Li, L., Li, C., Wang, S., Wang, Z., Jiang, J., Wang, W., Li, X., Chen, J., Liu, K., Li, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1625 · Cited by 532
Prima, V., Kaliberova, L. N., Kaliberov, S., Curiel, D. T., & Kusmartsev, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612920114 · Cited by 494
Wang, T., Gilkes, D. M., Takano, N., Xiang, L., Luo, W., Bishop, C. J., Chaturvedi, P., Green, J. J., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410041111 · Cited by 493
Hu, Y.-L., DeLay, M., Jahangiri, A., Molinaro, A. M., Rose, S. D., Carbonell, W. S., & Aghi, M. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3831 · Cited by 483
Autophagy in cancer metastasis
Mowers, E. E., Sharifi, M. N., & Macleod, K. F. (2017) · Oncogene · doi:10.1038/onc.2016.333 · Cited by 475
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Chen, L., Diao, L., Yang, Y., Yi, X., Rodriguez, B. L., Li, Y., Villalobos, P. A., Cascone, T., Liu, X., Tan, L., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1033 · Cited by 462
Self-citationTumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis
Abusamra, A. J., Zhong, Z., Zheng, X., Li, M., Ichim, T. E., Chin, J. L., & Min, W.-P. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2005.07.001 · Cited by 456
Chiu, D. K.-C., Tse, A. P.-W., Xu, I. M.-J., Di Cui, J., Lai, R. K.-H., Li, L. L., Koh, H.-Y., Tsang, F. H.-C., Wei, L. L., Wong, C.-M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00530-7 · Cited by 448
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
Huang, D., Chen, J., Yang, L., Ouyang, Q., Li, J., Lao, L., Zhao, J., Liu, J., Lu, Y., Xing, Y., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0207-y · Cited by 448
The ever-expanding role of HIF in tumour and stromal biology
LaGory, E. L., & Giaccia, A. J. (2016) · Nature Cell Biology · doi:10.1038/ncb3330 · Cited by 430
Zhang, H., Lu, H., Xiang, L., Bullen, J. W., Zhang, C., Samanta, D., Gilkes, D. M., He, J., & Semenza, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520032112 · Cited by 420
New insights into the role of EMT in tumor immune escape
Terry, S., Savagner, P., Ortiz‐Cuaran, S., Mahjoubi, L., Saintigny, P., Thiery, J., & Chouaib, S. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12093 · Cited by 414
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway
Wu, Q., Jiang, L., Li, S.-C., He, Q.-J., Yang, B., & Cao, J. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0366-x · Cited by 414
Self-citationPI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review)
Zhang, Z., Yao, L., Yang, J., Wang, Z., & Du, G. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9375 · Cited by 404
Semenza, G. L. (2017) · The EMBO Journal · doi:10.15252/embj.201695204 · Cited by 366
Ahluwalia, A., & S. Tarnawski, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803413944 · Cited by 359
Gonzalez-King, H., García, N. A., Ontoria-Oviedo, I., Ciria, M., Montero, J. A., & Sepúlveda, P. (2017) · Stem Cells · doi:10.1002/stem.2618 · Cited by 352
Baginska, J., Viry, E., Berchem, G., Poli, A., Noman, M. Z., van Moer, K., Medves, S., Zimmer, J., Oudin, A., Niclou, S. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304790110 · Cited by 344
Samanta, D., Park, Y., Ni, X., Li, H., Zahnow, C. A., Gabrielson, E., Pan, F., & Semenza, G. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718197115 · Cited by 302
Kaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0425 · Cited by 300
Li, J., Wang, L., Chen, X., Li, L., Li, Y., Ping, Y., Huang, L., Yue, D., Zhang, Z., Wang, F., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1320011 · Cited by 299
Self-citationSemenza, G. L. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.69 · Cited by 297
Lundholm, M., Schröder, M., Nagaeva, O., Baranov, V., Widmark, A., Mincheva-Nilsson, L., & Wikström, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108925 · Cited by 291
Pharmacologic Targeting of Hypoxia-Inducible Factors
Semenza, G. L. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021637 · Cited by 288
Xu, S., Tao, Z., Hai, B., Liang, H., Shi, Y., Wang, T., Song, W., Chen, Y., OuYang, J., Chen, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11406 · Cited by 287
Guo, X., Qiu, W., Liu, Q., Qian, M., Wang, S., Zhang, Z., Gao, X., Chen, Z., Xue, H., & Li, G. (2018) · Oncogene · doi:10.1038/s41388-018-0261-9 · Cited by 287
Tang, Y.-A., Chen, Y.-F., Bao, Y., Mahara, S., Yatim, S. M. J. M., Oguz, G., Lee, P. L., Feng, M., Cai, Y., Tan, E. Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801348115 · Cited by 277
Ye, L.-Y., Chen, W., Bai, X.-L., Xu, X.-Y., Zhang, Q., Xia, X.-F., Sun, X., Li, G.-G., Hu, Q.-D., Fu, Q.-H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0977 · Cited by 275
Meng, X., Grötsch, B., Luo, Y., Knaup, K. X., Wiesener, M. S., Chen, X.-X., Jantsch, J., Fillatreau, S., Schett, G., & Bozec, A. (2018) · Nature Communications · doi:10.1038/s41467-017-02683-x · Cited by 274
Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
Xiong, G., Stewart, R. L., Chen, J., Gao, T., Scott, T. L., Samayoa, L. M., O’Connor, K., Lane, A. N., & Xu, R. (2018) · Nature Communications · doi:10.1038/s41467-018-06893-9 · Cited by 274
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Vito, A., El-Sayes, N., & Mossman, K. (2020) · Cells · doi:10.3390/cells9040992 · Cited by 270
Cheng, J.-T., Deng, Y.-N., Yi, H.-M., Wang, G.-Y., Fu, B.-S., Chen, W.-J., Liu, W., Tai, Y., Peng, Y.-W., & Zhang, Q. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.7 · Cited by 267
The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia
Schietke, R., Warnecke, C., Wacker, I., Schödel, J., Mole, D. R., Campean, V., Amann, K., Goppelt-Struebe, M., Behrens, J., Eckardt, K.-U., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042424 · Cited by 253
Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals
Grimsley, C. (2003) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.10.004 · Cited by 250
Improving T Cell Therapy for Cancer
Leen, A. M., Rooney, C. M., & Foster, A. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141527 · Cited by 240
Ward, J. P., Gubin, M. M., & Schreiber, R. D. (2016) · Advances in Immunology · doi:10.1016/bs.ai.2016.01.001 · Cited by 228
Ye, Y., Xu, Y., Lai, Y., He, W., Li, Y., Wang, R., Luo, X., Chen, R., & Chen, T. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26509 · Cited by 225
Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
Martinez-Bosch, N., Vinaixa, J., & Navarro, P. (2018) · Cancers · doi:10.3390/cancers10010006 · Cited by 209
Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
Wang, Y., Wang, H., Yao, H., Li, C., Fang, J.-Y., & Xu, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00536 · Cited by 209
Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
Barsoum, I. B., Koti, M., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2598 · Cited by 201
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
Samanta, D., & Semenza, G. L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.002 · Cited by 190
Barsoum, I. B., Hamilton, T. K., Li, X., Cotechini, T., Miles, E. A., Siemens, D. R., & Graham, C. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2104 · Cited by 188
Palazón, A., Martínez-Forero, I., Teijeira, A., Morales-Kastresana, A., Alfaro, C., Sanmamed, M. F., Perez-Gracia, J. L., Peñuelas, I., Hervás-Stubbs, S., Rouzaut, A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0314 · Cited by 187
Black, M., Barsoum, I. B., Truesdell, P., Cotechini, T., Macdonald-Goodfellow, S. K., Petroff, M., Siemens, D. R., Koti, M., Craig, A. W. B., & Graham, C. H. (2016) · Oncotarget · doi:10.18632/oncotarget.7235 · Cited by 182
Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
Chouaib, S., Messai, Y., Couve, S., Escudier, B., Hasmim, M., & Noman, M. Z. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00021 · Cited by 180
Doublier, S., Belisario, D. C., Polimeni, M., Annaratone, L., Riganti, C., Allia, E., Ghigo, D., Bosia, A., & Sapino, A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-4 · Cited by 178
Ou, Z.-L., Luo, Z., Wei, W., Liang, S., Gao, T.-L., & Lu, Y.-B. (2019) · RNA Biology · doi:10.1080/15476286.2019.1649585 · Cited by 172
Vaupel, P., & Multhoff, G. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-91287-5_27 · Cited by 161
Yang, H., Zhou, W., Chang, K., Mei, J., Huang, L., Wang, M., Meng, Y., Ha, S., Li, D., & Li, M. (2017) · Reproduction · doi:10.1530/rep-17-0342 · Cited by 154
Ueno, M., Maeno, T., Nomura, M., Aoyagi, K., Matsui, H., Hara, K., Tanaka, T., Iso, T., Suga, T., & Kurabayashi, M. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00146.2010 · Cited by 146
miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS
Wu, M.-Z., Cheng, W., Chen, S.-F., Nieh, S., O’Connor, C., Liu, C., Tsai, W., Wu, C.-J., Martin, L., Lin, Y., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3615 · Cited by 140
Nan, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1197 · Cited by 129
Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion
Liu, X., Liu, L., Ren, Z., Yang, K., Xu, H., Luan, Y., Fu, K., Guo, J., Peng, H., Zhu, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.062 · Cited by 127
Sethumadhavan, S., Silva, M., Philbrook, P., Nguyen, T., Hatfield, S. M., Ohta, A., & Sitkovsky, M. V. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187314 · Cited by 119
Thepmalee, C., Panya, A., Junking, M., Chieochansin, T., & Yenchitsomanus, P. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1431598 · Cited by 108
Hypoxia-Induced Resistance to Chemotherapy in Cancer
Minassian, L. M., Cotechini, T., Huitema, E., & Graham, C. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_9 · Cited by 104
Lei, R. L., Li, J., Liu, F., Li, W., Zhang, S., Wang, Y., Chu, X., & Xu, J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1670508 · Cited by 104
Hypoxia-driven intratumor heterogeneity and immune evasion
Terry, S., Engelsen, A. S. T., Buart, S., El‐Sayed, W., Venkatesh, G. H., & Chouaïb, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.004 · Cited by 104
Hypoxia‑inducible factors in hepatocellular carcinoma (Review)
Guo, Y., Xiao, Z., Liu, Y., Gao, Y., Zhu, Q., Hu, L., Huang, D., & Xu, Q. (2019) · Oncology Reports · doi:10.3892/or.2019.7397 · Cited by 102
Hypoxia Mediates Tumor Malignancy and Therapy Resistance
Luo, W., & Wang, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_1 · Cited by 99
Autophagic degradation of GZMB/granzyme B
Viry, E., Bagińska, J., Berchem, G., Noman, M. Z., Medves, S., Chouaı̈b, S., & Janji, B. (2013) · Autophagy · doi:10.4161/auto.26924 · Cited by 92
EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells
Zhao, Y., Wang, X., Wu, W., Long, H., Huang, J., Wang, Z., Li, T., Tang, S., Zhu, B., & Chen, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.039 · Cited by 91
Self-citationJanji, B., Berchem, G., & Chouaïb, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00887 · Cited by 86
Xia, Y., Zhang, Q., Quan, Z., Zhao, Y., Liu, N., Li, T., Hao, Y., Zhang, Y., Luo, C., & Wu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.16354 · Cited by 85
Ryu, D., Kim, S. J., Hong, Y., Jo, A., Kim, N., Kim, H., Lee, H., Kım, K., & Park, W. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0694 · Cited by 83
Long, J., Hu, Z., Xue, H., Wang, Y., Chen, J., Tang, F., Zhou, J., Liu, L., Qiu, W., Zhang, S., et al. (2019) · Cancer Science · doi:10.1111/cas.14091 · Cited by 82
PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs
Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Zarrin, V., Moghadam, E. R., Zabolian, A., Tavakol, S., Samarghandian, S., & Najafi, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117899 · Cited by 82
Wu, H., Huang, S., Chen, Z., Liu, W., Zhou, X., & Zhang, D. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4255 · Cited by 77
Büchler, P., Reber, H. A., Tomlinson, J. S., Hankinson, O., Kallifatidis, G., Frieß, H., Herr, I., & Hines, O. J. (2009) · Neoplasia · doi:10.1593/neo.08734 · Cited by 76
Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells
Roncuzzi, L., Pancotti, F., & Baldini, N. (2014) · Oncology Reports · doi:10.3892/or.2014.3181 · Cited by 76
Pinato, D. J., Black, J. R., Trousil, S., Dina, R. E., Trivedi, P. S., Mauri, F. A., & Sharma, R. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1358332 · Cited by 72
Zhang, M., Gao, D., Shi, Y., Wang, Y., Joshi, R., Yu, Q., Liu, D., Alotaibi, F., Zhang, Y., Wang, H., et al. (2019) · Open Biology · doi:10.1098/rsob.190061 · Cited by 72
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71
Labiano, S., Palazón, A., Bolaños, E., Azpilikueta, A., Sánchez-Paulete, A. R., Morales‐Kastresana, A., Quetglas, J. I., Perez‐Gracia, J. L., Gúrpide, A., Rodriguez-Ruiz, M. E., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1062967 · Cited by 68
Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy
Tong, J., Xu, X., Zhang, Z., Ma, C.-N., Xiang, R., Liu, J., Xu, W., Wu, C., Li, J., Zhan, F., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.218289 · Cited by 68
Cheng, Z., Wang, D., LIU, T., Liu, W., Xia, W.-B., XU, J., ZHANG, Y.-H., Qu, Y., Guo, L., Ding, L., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3022 · Cited by 65
Lee, Y.-H., Bae, H. C., Noh, K. H., Song, K.-H., Ye, S.-K., Mao, C.-P., Lee, K.-M., Wu, T.-C., & Kim, T. W. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1979 · Cited by 64
The multifaceted role of autophagy in tumor evasion from immune surveillance
Janji, B., Viry, E., Moussay, E., Paggetti, J., Arakelian, T., Mgrditchian, T., Messai, Y., Noman, M. Z., Moer, K. V., Hasmim, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7540 · Cited by 62
Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer Cells
Garziera, M., Scarabel, L., & Toffoli, G. (2017) · Journal of Immunology Research · doi:10.1155/2017/4587520 · Cited by 62
Luo, W., & Wang, Y. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2684-9 · Cited by 59
Myeloid-derived suppressor cells in B cell malignancies
Yazdani, Y., Mohammadnia‐Afrouzi, M., Yousefi, M., Anvari, E., Ghalamfarsa, G., Hassannia, H., Sadreddini, S., & Jadidi‐Niaragh, F. (2015) · Tumor Biology · doi:10.1007/s13277-015-4004-z · Cited by 58
HIF-1 — A BIG CHAPTER IN THE CANCER TALE
Ajduković, J. J. (2016) · Experimental Oncology · doi:10.31768/2312-8852.2016.38(1):9-12 · Cited by 52
Zhang, L., Yu, Z., Tu, Q., Xue, X., Zhu, X., & Zhao, K. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200128105459 · Cited by 52
Cui, C., Fu, K., Yang, L., Wu, S., Cen, Z.-J., Meng, X., Huang, Q., & Xie, Z.-C. (2019) · Journal of experimental & clinical cancer research : CR · doi:10.1186/s13046-019-1233-9 · Cited by 49
Hypoxia-mediated immune evasion of pancreatic carcinoma cells
Lu, Y., Hu, J., Sun, W., Duan, X., & Chen, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3144 · Cited by 48
Winning, S., & Fandrey, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/5134329 · Cited by 48
Ryu, D., Kim, S. J., Hong, Y., Jo, A., Kim, N., Kim, H., Lee, H., Kım, K., & Park, W. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3174 · Cited by 47
Inverse Correlation between IL-10 and HIF-1α in Macrophages Infected with Histoplasma capsulatum
Fecher, R. A., Horwath, M. C., Friedrich, D., Rupp, J., & Deepe, G. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600342 · Cited by 44
Janker, L., Mayer, R. L., Bileck, A., Kreutz, D., Mader, J. C., Utpatel, K., Heudobler, D., Agis, H., Gerner, C., & Slany, A. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001390 · Cited by 44
Chang, H., Hsu, S., & Chien, C. (2019) · Antioxidants · doi:10.3390/antiox9010002 · Cited by 40
Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice
Kachapati, K., Bednar, K. J., Adams, D. E., Wu, Y., Mittler, R. S., Jordan, M. B., Hinerman, J. M., Herr, A. B., & Ridgway, W. M. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.09.002 · Cited by 38
Gai, X., Zhou, P., Xu, M. M., Liu, Z., Zheng, X. M., & Liu, Q. (2019) · Journal of Cancer · doi:10.7150/jca.35631 · Cited by 38
Wen, Q.-X., Han, T., Wang, Z., & Jiang, S. (2020) · Oncology Letters · doi:10.3892/ol.2020.11369 · Cited by 36
Robinson, C. M., Poon, B., Kano, Y., Pluthero, F. G., Kahr, W. H. A., & Ohh, M. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0461 · Cited by 33
Schilling, D., Tetzlaff, F., Konrad, S., Li, W., & Multhoff, G. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-014-0532-5 · Cited by 32
Targeting COX-2/PGE2 Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation
Garufi, A., Pistritto, G., Ceci, C., Renzo, L. D., Santarelli, R., Faggioni, A., Cirone, M., & D’Orazi, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048342 · Cited by 29
The evaluation of VEGF and HIF‐1α gene polymorphisms and multiple sclerosis susceptibility
Saravani, M., Rokni, M., Mehrbani, M., Amirkhosravi, A., Faramarz, S., Fatemi, I., Tarzi, M. E., & Nematollahi, M. H. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3132 · Cited by 29
Janardhan, H. P. (2008) · Science Signaling · doi:10.1126/scisignal.143jc2 · Cited by 23
Li, L., Dai, B., Yu-han, S., & Zhang, T. (2020) · Mediators of Inflammation · doi:10.1155/2020/4235909 · Cited by 20
Chen, Y., Yan, Q., Xu, Y., Ye, F., Sun, X., Zhu, H., & Wang, H. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666190509105502 · Cited by 19
Inhibiting HLA-G restores IFN-γ and TNF-α producing T cell in pleural Tuberculosis
Saurabh, A., Chakraborty, S., Kumar, P., Mohan, A., Bhatnagar, A. K., Rishi, N., & Mitra, D. K. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.01.008 · Cited by 15
Hypoxia and PGE2 Regulate MiTF-CX During Cervical Ripening
Kishore, A. H., Li, X.-H., & Word, R. A. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1100 · Cited by 12
Wein, D., & Gupta, S. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04146-8 · Cited by 9
Hypoxia-induced autophagy in tumor cells: a key target for improving cancer immunotherapy
(2014) · Cancer Cell & Microenvironment · doi:10.14800/ccm.213 · Cited by 5
Ming, P. (2014) · Medical Science Monitor · doi:10.12659/msm.891048 · Cited by 3
Cited by
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Wu, Q., You, L., Nepovimova, E., Heger, Z., Wu, W., Kuca, K., & Adam, V. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01292-6 · Cited by 485
Self-citationLiu, J., Peng, X., Yang, S., Li, X., Huang, M., Wei, S., Zhang, S., He, G., Zheng, H., Fan, Q., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-021-00816-w · Cited by 75
Signal transducer and activator of transcription 3 signaling in tumor immune evasion
Zhang, L., Kuca, K., You, L., Zhao, Y., Musilek, K., Nepovimova, E., Wu, Q., Wu, W., & Adam, V. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107969 · Cited by 67
Self-citationLi, C., Qin, C., Li, X., Wang, J., Li, Y., & Sun, Q. (2026) · International Journal of Oncology · doi:10.3892/ijo.2026.5845 · Cited by 3
Metadata
- Authors
- You, L., Wu, W., Wang, X., Fang, L., Adam, V., Nepovimova, E., Wu, Q., & Kuca, K.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2020-12-11
- Volume
- 41
- Issue
- 3
- Pages
- 1622-1643
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W3111889155
- Cited by
- 265
- References
- 127
- FWCI
- 11.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.